358 related articles for article (PubMed ID: 31190623)
1. Pharmacogenetic testing in primary care practice: opinions of physicians, pharmacists and patients.
Frigon MP; Blackburn MÈ; Dubois-Bouchard C; Gagnon AL; Tardif S; Tremblay K
Pharmacogenomics; 2019 Jun; 20(8):589-598. PubMed ID: 31190623
[No Abstract] [Full Text] [Related]
2. Pharmacogenetics in clinical practice: current level of knowledge among Flemish physicians and pharmacists.
Edris A; Vanoverschelde A; Bushaj P; Van Nieuwerburgh F; Lahousse L
Pharmacogenomics J; 2021 Feb; 21(1):78-84. PubMed ID: 32848197
[TBL] [Abstract][Full Text] [Related]
3. Primary care physician experiences with integrated pharmacogenomic testing in a community health system.
Lemke AA; Hutten Selkirk CG; Glaser NS; Sereika AW; Wake DT; Hulick PJ; Dunnenberger HM
Per Med; 2017 Sep; 14(5):389-400. PubMed ID: 29754567
[TBL] [Abstract][Full Text] [Related]
4. A nationwide cross-sectional survey of pharmacy students on pharmacogenetic testing in The Netherlands.
Bank PC; Swen JJ; Guchelaar HJ
Pharmacogenomics; 2018 Mar; 19(4):311-319. PubMed ID: 29473451
[TBL] [Abstract][Full Text] [Related]
5. Pilot study of pharmacist-assisted delivery of pharmacogenetic testing in a primary care setting.
Haga SB; LaPointe NM; Cho A; Reed SD; Mills R; Moaddeb J; Ginsburg GS
Pharmacogenomics; 2014 Sep; 15(13):1677-86. PubMed ID: 25410893
[TBL] [Abstract][Full Text] [Related]
6. Assessment of healthcare professionals' knowledge, attitudes, and perceived challenges of clinical pharmacogenetic testing in Egypt.
Nagy M; Lynch M; Kamal S; Mohamed S; Hadad A; Abouelnaga S; Aquilante CL
Per Med; 2020 Jul; 17(4):251-260. PubMed ID: 32589096
[No Abstract] [Full Text] [Related]
7. Experience and expectations of pharmacogenetic tests in France.
Verdez S; Bardou M; Duffourd Y; Luu M; Thauvin-Robinet C; Faivre L; Picard N
Therapie; 2024; 79(3):341-349. PubMed ID: 37516659
[TBL] [Abstract][Full Text] [Related]
8. A nationwide survey of pharmacists' perception of pharmacogenetics in the context of a clinical decision support system containing pharmacogenetics dosing recommendations.
Bank PC; Swen JJ; Guchelaar HJ
Pharmacogenomics; 2017 Feb; 18(3):215-225. PubMed ID: 28112992
[TBL] [Abstract][Full Text] [Related]
9. Preemptive pharmacogenetic testing to guide chemotherapy dosing in patients with gastrointestinal malignancies: a qualitative study of barriers to implementation.
Lau-Min KS; Varughese LA; Nelson MN; Cambareri C; Reddy NJ; Oyer RA; Teitelbaum UR; Tuteja S
BMC Cancer; 2022 Jan; 22(1):47. PubMed ID: 34996412
[TBL] [Abstract][Full Text] [Related]
10. Mapping the implementation of pharmacogenomic testing in community pharmacies 2003-2021 using the Theoretical Domains Framework: A scoping review.
Aref HAT; Makowsky MJ; Kung JY; Guirguis LM
J Am Pharm Assoc (2003); 2023; 63(2):459-476.e6. PubMed ID: 36371398
[TBL] [Abstract][Full Text] [Related]
11. Results of a nationwide survey of Japanese pharmacists regarding the application of pharmacogenomic testing in precision medicine.
Tsuji D; Saito Y; Mushiroda T; Miura M; Hira D; Terada T
J Clin Pharm Ther; 2021 Jun; 46(3):649-657. PubMed ID: 33555613
[TBL] [Abstract][Full Text] [Related]
12. Perspectives of Pediatric Providers Regarding Clinical Use of Pharmacogenetics.
Avello K; Bell M; Stein Q; Bares V; Landsverk M; Salyakina D; McCafferty-Fernandez J; Kingsmore S; Bedrick A; Bhojwani D; Hoyme HE
S D Med; 2021 Jul; 74(7):294-301. PubMed ID: 34449988
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetic Information in Clinical Guidelines: The European Perspective.
Swen JJ; Nijenhuis M; van Rhenen M; de Boer-Veger NJ; Buunk AM; Houwink EJF; Mulder H; Rongen GA; van Schaik RHN; van der Weide J; Wilffert B; Deneer VHM; Guchelaar HJ;
Clin Pharmacol Ther; 2018 May; 103(5):795-801. PubMed ID: 29460273
[TBL] [Abstract][Full Text] [Related]
14. Community pharmacists' experience with pharmacogenetic testing.
Moaddeb J; Mills R; Haga SB
J Am Pharm Assoc (2003); 2015; 55(6):587-594. PubMed ID: 26409205
[TBL] [Abstract][Full Text] [Related]
15. Assessment of primary care practitioners' attitudes and interest in pharmacogenomic testing.
Smith DM; Namvar T; Brown RP; Springfield TB; Peshkin BN; Walsh RJ; Welsh JC; Levin B; Brandt N; Swain SM
Pharmacogenomics; 2020 Oct; 21(15):1085-1094. PubMed ID: 32969759
[No Abstract] [Full Text] [Related]
16. Knowledge, perceptions and confidence of physicians and pharmacists towards pharmacogenetics practice in Kuwait.
Albassam A; Alshammari S; Ouda G; Koshy S; Awad A
PLoS One; 2018; 13(9):e0203033. PubMed ID: 30183746
[TBL] [Abstract][Full Text] [Related]
17. National survey of physicians' perspectives on pharmacogenetic testing in solid organ transplantation.
Deininger KM; Tsunoda SM; Hirsch JD; Anderson H; Lee YM; McIlvennan CK; Page RL; Tran JN; Aquilante CL
Clin Transplant; 2020 Oct; 34(10):e14037. PubMed ID: 32654213
[TBL] [Abstract][Full Text] [Related]
18. Pharmacist and physician perception of pharmacogenetic testing.
Bruno Xuereb AM; Wirth F; Mifsud Buhagiar L; Camilleri L; Azzopardi LM; Serracino-Inglott A
Int J Pharm Pract; 2022 May; 30(2):188-191. PubMed ID: 35225344
[TBL] [Abstract][Full Text] [Related]
19. Patient and healthcare professional acceptability of pharmacogenetic screening for DPYD and UGT1A1: A cross sectional survey.
Glewis S; Krishnasamy M; Lingaratnam S; Harris S; Underhill C; Georgiou C; Warren M; Campbell R; IJzerman M; Fagery M; Campbell I; Martin JH; Tie J; Alexander M; Michael M
Clin Transl Sci; 2023 Dec; 16(12):2700-2708. PubMed ID: 37877594
[TBL] [Abstract][Full Text] [Related]
20. Pharmacist-Initiated Pre-Emptive Pharmacogenetic Panel Testing with Clinical Decision Support in Primary Care: Record of PGx Results and Real-World Impact.
van der Wouden CH; Bank PCD; Özokcu K; Swen JJ; Guchelaar HJ
Genes (Basel); 2019 May; 10(6):. PubMed ID: 31146504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
